Amgen Unveils Major Manufacturing Expansion
Amgen (NASDAQ: AMGN) has just announced a significant investment of $900 million to expand its manufacturing facilities, aimed at enhancing its production capabilities. This expansion is expected to create 350 new jobs, highlighting Amgen's commitment to growing its workforce and boosting the local economy.
Total Investment Surpasses $1.4 Billion
This latest investment brings Amgen's total commitment in the region to over $1.4 billion, resulting in the creation of 750 jobs. Robert A. Bradway, the chairman and CEO of Amgen, emphasized the company's ongoing dedication to advancing U.S. manufacturing. He stated, "Today's investment reinforces our ongoing commitment to expanding U.S. manufacturing and ensuring patients around the world have access to our innovative medicines." This expansion supports Amgen's goal of providing innovative biologic medicines to patients globally.
Strategic Importance of the Expansion
The state of Ohio has been identified as an ideal location for this expansion due to its favorable business environment, skilled workforce, and strategic geographical position. The company recognized these factors as instrumental in deciding to deepen its investment in the area. Governor Mike DeWine of Ohio expressed enthusiasm for Amgen’s commitment, noting that the region has created a solid foundation for economic growth, making it a prime destination for businesses seeking to expand.
Amgen's Manufacturing Journey
Amgen entered Ohio's market in June 2021 with plans to invest in a state-of-the-art biomanufacturing facility, which previously created 400 jobs. This initial move has proven crucial for enhancing Amgen's manufacturing capabilities within the U.S. and supporting both its operational AND technological advancements. The recent announcement follows Amgen's decision to invest $1 billion in constructing an additional manufacturing plant in Holly Springs, NC, emphasizing a nationwide strategy to build cutting-edge biologics manufacturing facilities.
Economic Impact of Amgen’s Investments
Since the implementation of the Tax Cuts and Jobs Act of 2017, Amgen has invested nearly $5 billion in direct capital expenditures within the U.S. This has generated significant downstream economic output, contributing approximately $12 billion back to the economy. These investments underscore Amgen’s commitment to not only advancing its technology and operational capabilities but also to making a lasting positive impact on the communities where it operates.
About Amgen
Amgen has been on the forefront of biological medicine development for over four decades. The company is renowned for its unwavering commitment to innovation, utilizing technology and human genetic data to develop solutions for complex health challenges. Amgen's extensive pipeline aims at tackling various health issues, including cancer, heart disease, osteoporosis, rare diseases, and inflammatory disorders.
In addition to its focus on innovative therapies, Amgen has been recognized in 2024 as one of the "World's Most Innovative Companies" by Fast Company and listed among "America's Best Large Employers" by Forbes. Such accolades reflect Amgen’s outstanding reputation within the biotechnology sector, highlighting both its innovative spirit and commitment to employee satisfaction.
Connect with Amgen
To learn more about Amgen and its groundbreaking work in the biotechnology field, interested parties can visit Amgen's official website. The company is also active on various social media platforms, allowing individuals to stay updated on their latest news and contributions to the industry.
Frequently Asked Questions
What is the amount invested in the new manufacturing expansion?
The new expansion involves a significant investment of $900 million from Amgen.
How many jobs will be created with this expansion?
This investment is expected to create 350 new jobs within the manufacturing sector.
What is the total investment by Amgen in Ohio?
The total investment in Ohio is projected to exceed $1.4 billion, resulting in 750 jobs created.
How has Amgen contributed economically since 2017?
Since the Tax Cuts and Jobs Act of 2017, Amgen has invested around $5 billion in the U.S., leading to an economic output of approximately $12 billion.
What does Amgen focus on in its research and development?
Amgen focuses on innovative therapies for a range of diseases, including cancer, heart disease, and rare conditions, utilizing advanced genetic research.
